Effects of second-generation H1-antihistamine drugs on angiogenesis in in vivo chick chorioallantoic membrane model

被引:2
作者
Duman, Nilay [1 ]
Duman, Resat [2 ]
Vurmaz, Ayhan [3 ]
机构
[1] Ege Univ, Fac Med, Dept Dermatol, Izmir, Turkey
[2] Bakircay Univ, Cigli Reg Educ Hosp, Dept Ophthalmol, Izmir, Turkey
[3] Afyonkarahisar Hlth Sci Univ, Fac Med, Dept Biochem, Afyon, Turkey
关键词
Second-generation H1-antihistamines; angiogenesis; in vivo chick chorioallantoic membrane model; rupatadine; desloratadine; cetirizine; PLATELET-ACTIVATING-FACTOR; RECEPTOR ANTAGONIST; TUMOR-CELLS; CANCER;
D O I
10.1080/15569527.2022.2152040
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
BackgroundLiterature on the effects of second-generation H1-antihistamines on angiogenesis is limited.ObjectivesTo investigate the effects of cetirizine, desloratadine, and rupatadine (second-generation H1-antihistamines commonly used in dermatology clinics) on angiogenesis in an in vivo chick chorioallantoic membrane (CAM) model.MethodsThe study was approved by the local ethics committee on animal experimentation. Forty fertilized specific pathogen free eggs were incubated and kept under appropriate temperature and humidity control. Drug solutions were prepared in identical concentrations by dissolving powders in phosphate-buffered saline (PBS). On the third day of the incubation, a small window was opened on the CAM and 0.1 mL desloratadine (1.5 mu g/0.1 mL) in the first group, 0.1 mL cetirizine (1.5 mu g/0.1 mL) in the second group, 0.1 mL rupatadine in the third group (1.5 mu g/0.1 mL), and PBS (0.1 mL) in the fourth group were administered by injection. On the eighth day of incubation, the vascular structures of the CAMs were macroscopically examined and standard digital photographs were taken. The digital images were analyzed and data including mean vessel density, thickness, and number were compared between groups. p < 0.05 was considered statistically significant.ResultsVessel densities were similar in the desloratadine, cetirizine, and control groups, whereas they were significantly less in the rupatadine group (p = 0.01). Furthermore, the rupatadine group had significantly lower vessel thickness and number compared with the other groups (p < 0.05 for both).ConclusionsRupatadine showed anti-angiogenic effects in the chick CAM model, compared with desloratadine and cetirizine. The anti-angiogenic effect of rupatadine could be due to its platelet-activating factor (PAF) receptor inhibition. Thus, rupatadine could be a treatment agent in pathological processes in which angiogenesis is responsible. Further studies with larger series are needed to clarify this potential.
引用
收藏
页码:8 / 11
页数:4
相关论文
共 21 条
[1]  
[Anonymous], 2004, Biophotonics Int, DOI DOI 10.1201/9781420005615.AX4
[2]  
Barr?n S., 2006, REV RINOL, V6, P18
[3]  
Bergmann KC., 2014, CHEM IMMUNOL ALLERGY, P302
[4]   PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis [J].
Bussolati, B ;
Biancone, L ;
Cassoni, P ;
Russo, S ;
Rola-Pleszczynski, M ;
Montrucchio, G ;
Camussi, G .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (05) :1713-1725
[5]   PLATELET-ACTIVATING-FACTOR PRODUCED IN-VITRO BY KAPOSIS-SARCOMA CELLS INDUCES AND SUSTAINS IN-VIVO ANGIOGENESIS [J].
BUSSOLINO, F ;
ARESE, M ;
MONTRUCCHIO, G ;
BARRA, L ;
PRINO, L ;
BENELLI, R ;
SANAVIO, F ;
AGLIETTA, M ;
GHIGO, D ;
ROLAPLESZCZYNSKI, M ;
BOSIA, A ;
ALBINI, A ;
CAMUSSI, G .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (02) :940-952
[6]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[7]   CHICK EMBRYO CHORIOALLANTOIC MEMBRANE MODELS TO QUANTIFY ANGIOGENESIS INDUCED BY INFLAMMATORY AND TUMOR CELLS OR PURIFIED EFFECTOR MOLECULES [J].
Deryugina, Elena I. ;
Quigley, James P. .
ANGIOGENESIS: IN VIVO SYSTEMS, PT A, 2008, 444 :21-41
[8]   Platelet-Activating Factor Induces Th17 Cell Differentiation [J].
Drolet, Anne-Marie ;
Thivierge, Maryse ;
Turcotte, Sylvie ;
Hanna, Dominique ;
Maynard, Bruno ;
Stankova, Jana ;
Rola-Pleszczynski, Marek .
MEDIATORS OF INFLAMMATION, 2011, 2011
[9]   The Potential Role of Dietary Platelet-Activating Factor Inhibitors in Cancer Prevention and Treatment [J].
Lordan, Ronan ;
Tsoupras, Alexandros ;
Zabetakis, Ioannis .
ADVANCES IN NUTRITION, 2019, 10 (01) :148-164
[10]   Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells [J].
Ma, X ;
Ottino, P ;
Bazan, HEP ;
Bazan, NG .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 (09) :2915-2921